Rebound in community antibiotic consumption after the observed decrease during the COVID-19 pandemic, EU/EEA, 2022

We observed a rebound in consumption of antibacterials for systemic use (ATC J01) in the community sector in the European Union/European Economic Area during 2021 and 2022, after an observed decrease between 2019 and 2020. The rates in 2022 returned to pre-COVID-19-pandemic levels and were exceeded...

Descripción completa

Detalles Bibliográficos
Autores principales: Ventura-Gabarró, Cèlia, Leung, Vivian H, Vlahović-Palčevski, Vera, Machowska, Anna, Monnet, Dominique L, Högberg, Liselotte Diaz, Strauss, Reinhild, Catteau, Lucy, Stoikov, Ivan, Payerl-Pal, Marina, Kyriakidou, Isavella, Prokeš, Michal, Attauabi, Majda, Sepp, Janne, Sarvikivi, Emmi, Hider-Mlynarz, Karima, Schweickert, Birgitta, Mellou, Kassiani, Matuz, Maria, Halldórsdóttir, Anna Margrét, Gurpinar, Emre Umut, Fortinguerra, Filomena, Rutkovska, Ieva, Valinteliene, Rolanda, Saleh, Stéphanie, Zarb, Peter, Baltink, Jan, Blix, Hege Salvesen, Olcza-Pieńkowska, Anna, Silva, Ana, Popescu, Gabriel Adrian, Tesař, Tomáš, Subelj, Maja, López-Navas, Antonio, Obeid, Ragda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Centre for Disease Prevention and Control (ECDC) 2023
Materias:
Rapid Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10655206/
https://www.ncbi.nlm.nih.gov/pubmed/37971660
http://dx.doi.org/10.2807/1560-7917.ES.2023.28.46.2300604

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10655206/
https://www.ncbi.nlm.nih.gov/pubmed/37971660
http://dx.doi.org/10.2807/1560-7917.ES.2023.28.46.2300604

Ejemplares similares